STOCK TITAN

Cemtrex SEC Filings

CETX NASDAQ

Welcome to our dedicated page for Cemtrex SEC filings (Ticker: CETX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Cemtrex, Inc. (CETX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cemtrex is a diversified industrial and technology company with Security, Industrial, and Aerospace & Defense segments, and its filings offer detailed information on capital structure, acquisitions, and corporate actions that affect CETX shareholders.

Among the key documents are Form 8-K current reports, where Cemtrex discloses material events. Recent 8-K filings describe a 1-for-15 reverse stock split approved by the board to address Nasdaq listing requirements, a promissory note with Streeterville Capital, LLC used to fund potential acquisitions, and a share purchase agreement to acquire Invocon, Inc., a systems-engineering firm in aerospace and defense. Another 8-K details a securities purchase agreement for a registered direct offering of common stock and pre-funded warrants, including gross proceeds and closing terms.

Investors can also review filings related to equity and preferred stock, such as disclosures on Series 1 Preferred Stock dividends paid in additional preferred shares, and unregistered sales of equity securities. These documents explain dividend terms, preference amounts, and how preferred stock fits into Cemtrex’s capital structure.

Stock Titan enhances these filings with AI-powered summaries that highlight the main points of lengthy documents, helping readers quickly understand items such as reverse stock split mechanics, acquisition agreements, and financing terms. Real-time updates from the SEC’s EDGAR system ensure that new CETX filings, including future 10-K annual reports, 10-Q quarterly reports, and Form 4 insider transaction reports when available, are added promptly.

By using this page, investors can study Cemtrex’s official disclosures on acquisitions, financing arrangements, stock splits, and preferred stock dividends, while AI-generated insights help clarify complex legal and financial language.

Rhea-AI Summary

Cemtrex Inc. has called its 2026 annual shareholder meeting for May 15, 2026 at the Hyatt Regency Long Island to elect four directors and ratify Grassi & Co. as independent auditor. Shareholders of record as of March 17, 2026 can vote in person or by proxy.

Voting power is heavily influenced by preferred stock: 10,078,089 common shares carry 10,078,089 votes, 50,000 Series C Preferred shares carry 100,881,671 votes, and 2,776,819 Series 1 Preferred shares carry 5,553,638 votes, for a total of 116,513,398 votes. Saagar Govil is Chairman and CEO, with three independent directors serving on the audit committee.

The proxy details significant related-party arrangements, including royalty-based sale terms for Cemtrex XR businesses to the CEO and receivables from entities controlled by current and former executives, as well as continued net losses and pay-versus-performance data for named executive officers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Cemtrex Inc. filed an amended current report to add detailed financial statements and proforma information for its acquisition of Invocon Inc.. Cemtrex completed the deal on January 8, 2026, acquiring 100% of Invocon for $7,060,000 in cash, largely funded with new debt.

Invocon generated $3,783,978 in revenue and a net loss of $310,539 for the year ended December 31, 2024, then improved to revenue of $4,382,819 and net income of $647,551 for the nine months ended September 30, 2025. Proforma, the combined company would have had revenue of $81,764,777 and a net loss attributable to Cemtrex shareholders of $29,347,873 for the year ended September 30, 2025, reflecting added interest expense from the acquisition financing and preliminary goodwill recognition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cemtrex, Inc. announced that its Board of Directors has approved paying the upcoming dividend on its Series 1 Preferred Stock in additional shares of Series 1 Preferred Stock rather than in cash. The dividend will be issued on April 7, 2026 to holders of record at the close of business on March 31, 2026.

Holders of the Series 1 Preferred Stock are entitled to receive dividends at a rate of 10% annually, based on the $10.00 per share preference amount, with payments made on a semiannual schedule. Using stock to satisfy this dividend preserves cash while still honoring the stated preferred dividend terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Cemtrex, Inc. approved a reverse stock split. The Board and holders by majority written consent authorized a reverse split at a ratio between 1-for-3 and 1-for-50, with the Board able to set the exact whole-number ratio at any time within 12 months after the consent.

The approval was by written consent on February 27, 2026 for holders of record as of March 6, 2026. As of that record date, 10,078,089 shares of Common Stock were outstanding; the total voting power eligible was 116,513,398 votes, and holders representing 101,219,376 votes (approximately 86.87%) voted in favor. The Board retains discretion whether and when to file the Certificate of Amendment to effect the Reverse Split and may abandon it prior to filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Cemtrex, Inc. has notified stockholders that holders holding a majority of voting power approved, by written consent, authorization for the Board to implement a reverse split of common stock at a ratio between 1-for-3 and 1-for-50, exercisable at the Board's discretion for 12 months.

The action was approved by holders controlling 101,219,376 votes (approx. 86.87%) of the 116,513,398 total voting power as of the Record Date. The Board may file the Certificate of Amendment to effect the split; timing and final ratio are at the Board's sole discretion. The reverse split is described as a tool to help maintain Nasdaq listing compliance and to permit flexibility, but it may not increase market capitalization and could affect liquidity and warrant adjustments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Cemtrex, Inc. reported a larger-than-normal quarterly loss despite higher sales. For the three months ended December 31, 2025, revenue rose to $16.1 million from $13.7 million, but net loss was still $20.6 million, driven mainly by $12.1 million of interest expense and $4.7 million of warrant-related losses.

Cash and cash equivalents increased sharply to $20.5 million, helped by $5.7 million of warrant exercises, $6.0 million of equity offerings, and a $7.0 million note. Common shares outstanding jumped to 8.6 million at December 31, 2025, and 10.1 million by February 13, 2026, reflecting significant dilution.

Management explicitly states that recurring losses of $28.1 million in fiscal 2025, a $20.6 million quarterly loss, and $6.7 million of debt due within a year raise substantial doubt about Cemtrex’s ability to continue as a going concern. Subsequent to quarter-end, Cemtrex completed a $7.06 million cash acquisition of Invocon and a Tennessee industrial services acquisition funded with new bank debt and a $4.9 million mortgage.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Cemtrex Inc. investors reported a significant ownership position in the company’s common stock. As of the close of business on December 31, 2025, the reporting persons may be deemed to beneficially own 605,011 shares of common stock issuable upon exercise of a warrant, representing approximately 7.3% of the class.

This percentage is based on 7,711,663 shares of common stock outstanding as of December 29, 2025, plus the warrant shares. The position is held through Intracoastal Capital LLC and attributed to Mitchell P. Kopin and Daniel B. Asher, who share voting and dispositive power and certify the holding is not for changing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Cemtrex, Inc., through its Advanced Industrial Services subsidiary, completed the acquisition of substantially all assets of Richland Industries in Tennessee and bought its main operating facility. AIS paid $600,000 for the business assets and $4,900,000 for the Pulaski facility.

The business asset purchase was financed with a Fulton Bank note at 6.09% interest maturing February 1, 2031. The real estate purchase was funded with a $3,920,000 Fulton Bank mortgage at SOFR plus 2.75% maturing February 1, 2041, plus cash for the remaining price and closing costs.

Richland’s operations are being integrated into Cemtrex’s Industrial Services segment via new subsidiary AIS Tennessee. Based on historical performance and current backlog, AIS Tennessee is expected to contribute approximately $8 to $10M in revenue over the next twelve months, expanding AIS’s presence in the Southeastern U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cemtrex, Inc. filed Amendment No. 1 to its annual report for the year ended September 30, 2025 to add Exhibit 97.1, the company’s Clawback Policy required under SEC Rule 10D-1. The amendment also includes new CEO and CFO certifications under Sections 302 of the Sarbanes-Oxley Act, with certain paragraphs omitted because no financial statements are included.

The company states that, aside from adding the clawback policy and updated certifications, no other parts of the original report are changed or updated. As context, common stock held by non-affiliates was 118,982 shares with an aggregate market value of $2,623,509 as of March 31, 2025, and 6,911,663 shares were outstanding as of December 22, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

Cemtrex, Inc. is conducting a registered direct primary offering of up to $4,000,000 of common stock or pre-funded warrants to a single accredited institutional investor at $2.722 per share or $2.721 per pre-funded warrant. Assuming only shares are issued, this implies up to 1,469,507 shares or an equal number of warrant shares. As of January 8, 2026, Cemtrex had 8,600,552 common shares outstanding and a public float of about $60.6 million.

The company expects net proceeds of approximately $3,950,000, to be used for working capital and general corporate purposes, including potential future acquisitions. No underwriter or placement agent is involved. Investors face significant dilution, with an estimated dilution of about $2.05 per share based on recent share issuances.

Cemtrex reports large net losses of $28.1 million in 2025 and $7.2 million in 2024 and substantial near‑term debt, leading auditors to express substantial doubt about its ability to continue as a going concern. Recent actions include multiple reverse stock splits, several equity offerings, a $7,025,000 promissory note, and a $7,060,000 cash acquisition of aerospace firm Invocon, which forms a new Aerospace & Defense segment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Cemtrex (CETX) SEC filings are available on StockTitan?

StockTitan tracks 20 SEC filings for Cemtrex (CETX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cemtrex (CETX)?

The most recent SEC filing for Cemtrex (CETX) was filed on March 26, 2026.